Thrombosis

Cardiovascular·MeSH: Thrombosis

15 drugs in development·11 companies·3 clinical trials

Drug Pipeline by Phase

Approved(11)

Drug	Company
Alginic Sodium Diester Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
apixaban	Mylan II B.V. (MYL)
apixaban	Impax Laboratories, LLC (IPXL)
enoxaparin	Amphastar Pharmaceuticals, Inc. (AMPH)
heparin	PFIZER INC (PFE)
prasugrel	Mylan II B.V. (MYL)
propylgallate	CHINA PHARMA HOLDINGS, INC. (CPHI)
Propylgallate for Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
ticagrelor	Mylan II B.V. (MYL)
ticagrelor	DR REDDYS LABORATORIES LTD (RDY)
ticagrelor	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(2)

Drug	Company
angiomax	SCICLONE PHARMACEUTICALS INC (SCLN)
Apixaban	UNITED THERAPEUTICS Corp (UTHR)

Phase 2(1)

Drug	Company
regn7508	REGENERON PHARMACEUTICALS, INC. (REGN)

Phase 2/Phase 3(1)

Drug	Company
tecarfarin	Cadrenal Therapeutics, Inc. (CVKD)

BioSniper tracks 15 drugs in development for Thrombosis across 11 companies.

There are 3 clinical trials targeting Thrombosis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.